NYXOID® is a nasal spray used for the emergency treatment of opioid overdose or possible opioid overdose in adults and adolescents aged 14 years and over.
NYXOID is a General Sale Medicine.
ALWAYS READ THE LABEL. USE AS DIRECTED
NYXOID® nasal spray contains the active substance naloxone. Naloxone temporarily reverses the effects of opioids such as heroin, methadone, fentanyl, oxycodone, buprenorphine and morphine.
NYXOID® nasal spray should be carried by anyone at risk of overdosing on an opioid. Carers such as close family or friends should know where to find NYXOID® in case of emergency.
NYXOID® is not a substitute for emergency medical care.
NYXOID® is intended as part of an emergency treatment and the patient/carer should be advised to seek medical help immediately. If you know or suspect that someone has overdosed on an opioid drug ALWAYS call an ambulance immediately.
Nyxoid has risks and benefits. Further information on the risks and benefits of this medicine can be found in the Consumer Medicines Information (CMI), available at the Medsafe website www.medsafe.govt.nz
Please refer to the following information for detailed instructions on how to use NYXOID for the emergency treatment of opioid overdose or possible opioid overdose:
TAPS Approval No: NA 13014